Cambridge Cancer Centre: the vision
04 January 2010Professor Sir Bruce Ponder describes the vision of a Cambridge-wide initiative to link world-class cancer research to improved patient care.
Research
Professor Sir Bruce Ponder describes the vision of a Cambridge-wide initiative to link world-class cancer research to improved patient care.
Computational biology is helping scientists to navigate through the data deluge generated from the analysis of cancer genomes.
Cambridge scientists are asking what role stem cells play in how cancer develops, spreads and relapses.
Cancer cells can now be viewed as never before, thanks to cutting-edge imaging tools being developed in Cambridge.
Researchers in the Department of Pathology have established precisely how the ‘cutting and pasting’ of genetic material from one chromosome to another results in cancer.
Scientists at Strangeways Research Laboratory are leading the search for the ‘genetic cards’ that determine an individual’s risk of cancer.
Rolls-Royce and the Engineering and Physical Sciences Research Council will work jointly with the Universities of Cambridge, Birmingham and Swansea in a new £50 million...
PneumaCare, the first company to receive funding from the University of Cambridge Discovery Fund, is a new model for utilising academic expertise.
A new generation of cancer therapeutics is on the horizon thanks to fresh light being shed on how genes are switched on and off.
A new chapter in textual scholarship is beginning, thanks to the launch of the Centre for Material Texts.